|

Switch Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Dartmouth-Hitchcock Medical Center1

Indications

  • Adjuvant Treatment1
  • Early-stage Breast Cancer1
  • Breast Cancer1
  • Cancer1

Lebanon, New Hampshire1 trial

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

Dartmouth Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.